BioSpace News Archive

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Rebecca Robertson as Chair of its Board of Directors.

Neuronetics, Inc. (NASDAQ: STIM) today announced that it plans to release fourth quarter 2022 financial and operating results prior to market open on Tuesday, March 7th, 2023.

Amicus Therapeutics (Nasdaq: FOLD) today announced positive results from the global Phase 3 open-label extension (OLE) study (ATB200-07) to investigate the long-term efficacy and safety of AT-GAA in adult patients with late-onset Pompe disease, an inherited lysosomal disorder caused by an enzyme deficiency that leads to the accumulation of glycogen in cells.

Lucira Health, Inc., a medical technology company, announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today presented data suggesting that tesamorelin may improve metabolic profiles in people with HIV (PWHIV) by reducing excess visceral abdominal fat (EVAF).

Aprea Therapeutics, Inc. announced the pricing of its previously announced underwritten public offering of 1,050,000 shares of its common stock at a public offering price of $5.25 per share.

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the fourth quarter and full year ended December 31, 2022.

Nexus Pharmaceuticals, Inc. announced the launch of its new product line – Sterile Vials from Nexus Pharmaceuticals.

Denali Therapeutics Inc. (NASDAQ: DNLI) today announced new interim results from the ongoing open-label, single-arm Phase 1/2 study of DNL310 (ETV:IDS) in children with MPS II (Hunter syndrome), including data from additional participants and up to 104 weeks of treatment.

ImmunoGen, Inc. announced that the following presentations by Company management at upcoming investor conferences will be webcast: Cowen 43rd Annual Health Care Conference March 8 at 9:10am ET Barclays Global Healthcare Conference March 15 at 10:15am ET A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com.